Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL

Dr Sara Ghorashian - University College London, London, UK
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL ( Dr Sara Ghorashian - University College London, London, UK )
23 Sep 2016

DNA methylation as a mediator of in utero exposures on the risk of childhood ALL

Jessica Timms - PhD student, Newcastle University, Newcastle, UK
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL ( Jessica Timms - PhD student, Newcastle University, Newcastle, UK )
23 Sep 2016

The timeline of adjuvant and neoadjuvant therapy for melanoma

Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France
The timeline of adjuvant and neoadjuvant therapy for melanoma ( Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France )
23 Sep 2016

Effects of ultraviolet light on underlying genes behind at-risk phenotypes

Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia
Effects of ultraviolet light on underlying genes behind at-risk phenotypes ( Prof Nick Hayward  - QIMR Berghofer, Brisbane, Australia )
23 Sep 2016

Metabolic regulation of melanoma cells

Dr Victoria Sherwood - University of Dundee, UK
Metabolic regulation of melanoma cells ( Dr Victoria Sherwood - University of Dundee, UK )
23 Sep 2016

Developments in checkpoint immunotherapy

Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK
Developments in checkpoint immunotherapy ( Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK )
22 Sep 2016

Targetted medicine to reduce melanoma mutational burden

Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia
Targetted medicine to reduce melanoma mutational burden ( Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia )
22 Sep 2016

VISMO trial to treat basal cell carcinoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany
VISMO trial to treat basal cell carcinoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
22 Sep 2016

Checkpoint inhibitor therapy for treating melanoma

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
Checkpoint inhibitor therapy for treating melanoma ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )
22 Sep 2016

Metabolomics: Reversing drug resistance

Dr Olivier Pardo - Imperial College London, London, UK
Metabolomics: Reversing drug resistance ( Dr Olivier Pardo - Imperial College London, London, UK )
14 Sep 2016

Tumour heterogeneity and the impact on patient care

Dr Nicholas McGranahan - The Francis Crick Institute, London, UK
Tumour heterogeneity and the impact on patient care ( Dr Nicholas McGranahan - The Francis Crick Institute, London, UK )
14 Sep 2016

Developing new models in SCLC

Prof Caroline Dive - Cancer Research UK Manchester Institute, Manchester, UK
Developing new models in SCLC ( Prof Caroline Dive - Cancer Research UK Manchester Institute, Manchester, UK )
14 Sep 2016